Welcome to our dedicated page for Maximus SEC filings (Ticker: MMS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Maximus runs large-scale health, welfare-to-work, and technology contracts for governments worldwide; that mix of service lines makes its SEC disclosures anything but straightforward. If you’ve ever searched “Where can I read the Maximus quarterly earnings report 10-Q filing?” or tried to decode revenue by segment in the annual 10-K, you know the challenge.
Stock Titan solves that complexity. Our AI engine scans every Maximus SEC filing the instant it hits EDGAR—whether it’s a Form 8-K announcing a new Medicaid contract or the proxy statement detailing executive compensation. You’ll see AI-powered summaries that turn legal prose into plain language, answering queries like “Maximus 8-K material events explained,” “understanding Maximus SEC documents with AI,” and delivering Maximus insider trading Form 4 transactions in real time.
- 10-K – Maximus annual report 10-K simplified with backlog and segment margin breakdowns.
- 10-Q – Maximus earnings report filing analysis that compares quarter-over-quarter trends.
- Form 4 – Maximus Form 4 insider transactions real-time for tracking executive stock activity.
- 8-K – Material contract wins and amendments distilled in minutes.
- DEF 14A – Maximus proxy statement executive compensation laid out clearly.
Whether you’re screening for cash-flow swings, monitoring “Maximus executive stock transactions Form 4,” or simply want “Maximus SEC filings explained simply,” our expert analysis, AI-generated highlights, and continuous updates deliver the insights you need—without wading through hundreds of pages.
Maximus, Inc. disclosed that Chief Legal Officer and Corporate Secretary John T. Martinez notified the company on December 15, 2025 of his intention to resign, effective February 15, 2026.
The company states that his decision is solely driven by a personal desire to pursue a new opportunity aligned with his industry background and is not due to any disagreement regarding operations, policies, or practices. Martinez will remain in his current role until his departure, and Maximus has begun a search for his successor.
Maximus, Inc. CEO and President David Mutryn reported equity transactions in the company’s common stock. On 12/02/2025, he acquired 13,391.387 shares at $0 when previously granted performance stock units vested, including 414.003 shares from dividend equivalent rights. On the same date, he surrendered 39,036.754 shares at $86.51 to cover withholding taxes tied to this vesting. After these transactions, he continued to directly hold a significant number of Maximus shares.
MAXIMUS, Inc. insider equity award activity is reported for the company’s Chief Financial Officer. On December 2, 2025, the officer acquired 13,391.387 shares of common stock at $0 per share following the release of previously granted performance stock units. This amount includes 414.003 shares from dividend equivalent rights tied to those units.
On the same date, the officer surrendered 6,039.515 shares of common stock at a price of $86.51 per share to cover withholding taxes related to the award. After these transactions, the officer directly owned 39,036.754 shares of MAXIMUS common stock.
MAXIMUS, INC. officer equity award vests and shares withheld for taxes. A company officer, General Manager - Health & Human, reported the release of 7,647.465 shares of common stock on 12/02/2025 from previously granted performance stock units. This amount includes 236.401 shares from dividend equivalent rights on the performance stock units granted on November 25, 2022.
The officer then surrendered 3,831.38 shares at a price of $86.51 per share to cover withholding taxes related to the award’s release. After these transactions, the officer beneficially owns 25,392.859 shares of MAXIMUS common stock directly.
Maximus, Inc. officer Theresa D. Golinvaux, Principal Accounting Officer, reported equity transactions in company common stock. On 12/02/2025, she acquired 1,200.769 shares of common stock at $0 upon the release of performance stock units granted on November 25, 2022, including 37.131 shares from dividend equivalent rights. On the same date, she surrendered 541.547 shares at $86.51 to cover withholding taxes tied to the PSU release. After these transactions, she beneficially owns 13,487.77 shares of Maximus common stock directly.
Maximus, Inc. officer Michelle Link, Chief of Human Resources, reported several stock transactions. On 12/02/2025, she acquired 7,358.338 shares of common stock at $0 from the release of performance stock units granted on November 25, 2022, including 227.500 shares from dividend equivalents. On the same day, she surrendered 3,318.61 shares at $86.51 to cover withholding taxes related to this PSU release. On 12/03/2025, she sold 4,039 shares at $86.84, under a Rule 10b5-1 trading plan adopted on December 6, 2024. After these transactions, she directly owned 19,541.801 shares of Maximus common stock.
An affiliate of MMS has filed a notice under Rule 144 to sell 4,039 shares of the issuer’s common stock through Fidelity Brokerage Services LLC on the NYSE. The planned sale has an indicated aggregate market value of $350,746.76, with the issuer reporting 54,461,507 shares of common stock outstanding. The shares were acquired on 12/02/2025 through a restricted stock vesting transaction from the issuer as compensation, with payment also dated 12/02/2025.
The notice also reports that the same seller, Michelle F. Link, previously sold 1,610 shares of common stock on 10/01/2025 for $146,284.60 over the prior three months. By signing the notice, the seller represents that they do not know of any material adverse, nonpublic information about the issuer’s current or prospective operations.
MAXIMUS, INC. director reported a change in ownership involving a gift of company stock. On 12/01/2025, the reporting person made a gift of 12,000 shares of common stock that had been held indirectly in a trust. The transaction is coded as a gift and shows no sale price, indicating it was a transfer without consideration. After this transaction, the reporting person beneficially owns 55,500 shares of MAXIMUS common stock indirectly through a trust. This filing records the updated ownership position but does not reflect an open-market purchase or sale.
Maximus, Inc. reported an equity compensation-related share increase for a senior executive. Chief Legal Officer John T. Martinez acquired 32.937 shares of Maximus common stock on 12/01/2025. The shares reflect dividend equivalent rights that accrued on previously awarded restricted stock units, with each right equal in value to one share of Maximus common stock and vesting proportionately with the related RSUs. Following this transaction, Martinez directly beneficially owns 22,641.129 shares of Maximus common stock.
Maximus, Inc. reported an insider equity update for its Chief Financial Officer, who filed individually. On 12/01/2025, the officer acquired 36.924 shares of common stock at a price of $0. These were dividend equivalent rights that accrued on previously awarded restricted stock units, and they vest proportionately with the underlying RSUs. Following this transaction, the officer beneficially owns 31,684.882 shares of Maximus common stock in direct ownership form.
FAQ
What is the current stock price of Maximus (MMS)?
What is the market cap of Maximus (MMS)?
